Efficacy of Lamivudine in patients with cirrhosis due to hepatitis B.

被引：0
|
作者：
Moskovitz, DN [1 ]
Lilly, LB [1 ]
Tomlinson, G [1 ]
Heathcote, J [1 ]
机构：
[1] Univ Hlth Network, Toronto, ON, Canada
来源：
HEPATOLOGY | 2001年 / 34卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1812
引用
收藏
页码：625A / 625A
页数：1
相关论文
共 50 条
  • [31] Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation
    Bain, VG
    Kneteman, NM
    Ma, MM
    Gutfreund, K
    Shapiro, JA
    Fischer, K
    Tipples, G
    Lee, H
    Jewell, LD
    Tyrrell, DL
    TRANSPLANTATION, 1996, 62 (10) : 1456 - 1462
  • [32] Two years lamivudine therapy in patients with chronic hepatitis B. Analysis of efficacy and emergence of HBV genomic variations
    Buti, M
    Jardi, R
    Cotrina, M
    Rodriguez-Frias, E
    de Castro, EC
    Costa, X
    Esteban, R
    Guardia, J
    JOURNAL OF HEPATOLOGY, 2000, 32 : 111 - 111
  • [33] Resistance to adefovir dipivoxil in patients with lamivudine-resistant chronic hepatitis B.
    Osiowy, C
    Heathcote, J
    Zoulim, F
    Willems, B
    Villeneuve, JP
    HEPATOLOGY, 2005, 42 (04) : 586A - 587A
  • [34] Lamivudine treatment for liver transplant patients with recurrent or de novo hepatitis B.
    Andreone, P
    Caraceni, P
    Grazi, GL
    Ercolani, G
    Milandri, GL
    Morelli, C
    Biselli, M
    Polifemo, AM
    DalMonte, PR
    Roda, E
    Mazziotti, A
    Cavallari, A
    Bernardi, M
    HEPATOLOGY, 1997, 26 (04) : 1380 - 1380
  • [35] Lamivudine treatment in patients with decompensated liver disease due to HBeAg negative chronic hepatitis B. A multicenter study.
    Manolakopoulos, S
    Karatapanis, S
    Elefsiniotis, J
    Goulis, J
    Mathou, N
    Vlachogiannakos, J
    Iliadou, E
    Kougioumtzan, A
    Economou, M
    Tzourmakliotis, D
    Avgerinos, A
    HEPATOLOGY, 2002, 36 (04) : 645A - 645A
  • [36] Genotypic and phenotypic resistance to lamivudine in patients with HBeAg negative chronic hepatitis B.
    Hussain, MT
    Carmela, C
    Gramenzi, A
    Fiorino, S
    Margotti, M
    Talarico, S
    Bernardi, M
    Andreone, P
    Lok, AS
    HEPATOLOGY, 2001, 34 (04) : 325A - 325A
  • [37] Efficacy of lamivudine and mutations to lamivudine in patients with chronic hepatitis B in North-West Greece
    Tsianos, EV
    Christodoulou, DK
    Kistis, KG
    Familias, I
    Tzabouras, N
    Zervou, E
    Katsanos, KH
    Baltayannis, G
    HEPATOLOGY, 1999, 30 (04) : 644A - 644A
  • [38] Efficacy of Entecavir in Patients with Chronic Hepatitis B Resistant to Both Lamivudine and Adefovir or to Lamivudine Alone
    Shim, Ju Hyun
    Suh, Dong Jin
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    Chung, Young-Hwa
    Lee, Yung Sang
    HEPATOLOGY, 2009, 50 (04) : 1064 - 1071
  • [39] The efficacy of lamivudine treatment of chronic hepatitis B in Thai patients.
    Hongsirinirachorn, M
    Chutaputti, A
    GASTROENTEROLOGY, 2000, 118 (04) : A1448 - A1448
  • [40] Efficacy of lamivudine for prophylaxis and treatment of hepatitis B in liver transplant patients
    Markowitz, J
    Pakrasi, A
    Hollis, P
    Martin, P
    Goldstein, L
    Busuttil, R
    HEPATOLOGY, 1996, 24 (04) : 222 - 222
12345